Paul Hastings Advises Piper Sandler, BTIG and Brookline Capital Markets on Outlook Therapeutics' Public Offering of Common Stock and Warrants
August 14, 2026
August 14, 2026
LOS ANGELES, California, Aug. 14 [Category: BizLaw/Legal] -- Paul Hastings, a law firm, issued the following news:
* * *
Paul Hastings Advises Piper Sandler, BTIG and Brookline Capital Markets on Outlook Therapeutics' Public Offering of Common Stock and Warrants
*
Paul Hastings LLP advised Piper Sandler, BTIG and Brookline Capital Markets as underwriters in a public offering by Outlook Therapeutics (Nasdaq: OTLK) of 55,555,556 shares of it . . .
* * *
Paul Hastings Advises Piper Sandler, BTIG and Brookline Capital Markets on Outlook Therapeutics' Public Offering of Common Stock and Warrants
*
Paul Hastings LLP advised Piper Sandler, BTIG and Brookline Capital Markets as underwriters in a public offering by Outlook Therapeutics (Nasdaq: OTLK) of 55,555,556 shares of it . . .
